Regenxbio Inc (RGNX)
Inventory turnover
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cost of revenue (ttm) | US$ in thousands | 137,951 | 137,678 | 136,222 | 136,832 | 146,534 | 148,063 | 154,183 | 148,644 | 133,201 | 111,133 | 111,921 | 103,915 | 98,968 | 95,847 | 69,820 | 64,914 | 57,879 | 54,573 | 48,685 | 41,671 |
Inventory | US$ in thousands | — | 12,561 | 15,112 | 15,521 | 13,900 | 14,824 | 16,245 | 18,542 | 18,752 | 18,401 | 13,092 | 13,839 | 10,505 | 16,112 | 9,749 | 7,422 | 6,475 | 6,920 | 6,036 | 6,292 |
Inventory turnover | — | 10.96 | 9.01 | 8.82 | 10.54 | 9.99 | 9.49 | 8.02 | 7.10 | 6.04 | 8.55 | 7.51 | 9.42 | 5.95 | 7.16 | 8.75 | 8.94 | 7.89 | 8.07 | 6.62 |
December 31, 2023 calculation
Inventory turnover = Cost of revenue (ttm) ÷ Inventory
= $137,951K ÷ $—K
= —
I'm sorry, but without specific values for inventory turnover for Regenxbio Inc across the specified quarters, a detailed analysis cannot be provided. To analyze inventory turnover effectively, we would need the cost of goods sold and average inventory figures for each quarter. These data points are essential for calculating the inventory turnover ratio, which helps in assessing how efficiently a company is managing its inventory. If you are able to provide the necessary data, I would be happy to assist you in conducting a thorough analysis of Regenxbio Inc's inventory turnover.
Peer comparison
Dec 31, 2023
Dec 31, 2023
Company name
Symbol
Inventory turnover
Regenxbio Inc
RGNX
—
ADMA Biologics Inc
ADMA
1.14
Amgen Inc
AMGN
1.88
Bio-Techne Corp
TECH
3.75
Biogen Inc
BIIB
2.19
Gilead Sciences Inc
GILD
8.79
Halozyme Therapeutics Inc
HALO
3.31
Krystal Biotech Inc
KRYS
8.87
Moderna Inc
MRNA
35.39
Neurocrine Biosciences Inc
NBIX
24.26
Repligen Corporation
RGEN
2.93